Gene expression profiling by cDNA array in human hepatoma cell line in response to cisplatin treatment

Life Sciences

Volumn 70, Issue 14, 2002, Pages 1677-1690

  Qin, Lan F ^a   Lee, Terence K W ^a   Ng, Irene O L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

cDNA array; Cisplatin; Gene expression profile; Hepatoma

Indexed keywords

ABELSON KINASE; APOLIPOPROTEIN; CASPASE 3; CELL CYCLE PROTEIN; CISPLATIN; COMPLEMENTARY DNA; CYCLIN B1; CYCLIN C; CYCLIN D1; DNA BINDING PROTEIN; FAS ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN P33ING1; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; PROTEIN SIVA; PROTEIN TYROSINE KINASE; PROTEIN WSL; RAF PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG MECHANISM; DRUG RESPONSE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CASPASES; CELL CYCLE PROTEINS; CISPLATIN; DNA FRAGMENTATION; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENES, P53; HUMANS; IN SITU NICK-END LABELING; LIVER NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0037154778     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01554-5     Document Type: Article

References (33)

1. Activation of programmed cell death by anticancer agents: Cisplatin as a model system
2. Role of oncogenes in resistance and killing by cancer therapeutic agents
3. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation
4. A gene expression database for the molecular pharmacology of cancer
5. Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells
6. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma
7. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas
8. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese
9. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents
10. Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase
11. Determination of cell fate by c-Abl activation in the response to DNA damage
12. The Bcl-2 protein family: Arbiters of cell survival
13. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax
14. Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells
15. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein
16. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
17. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways
18. Induction of the growth inhibitor IGF-binding protein 3 by p53
19. Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells
20. Cyclin-dependent kinase 5 activity enhances monocytic phenotype and cell cycle traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells
21. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control
22. Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas
23. Mechanisms regulating Raf-1 activity in signal transduction pathways
24. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
25. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
26. Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells
27. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway
28. Anti-apoptotic versus pro-apoptotic signal transduction: Checkpoints and stop signs along the road to death
29. The ras-related small GTP-binding protein RhoB is immediate-early inducible by DNA damaging treatments
30. Utilization of multiple polyadenylation signals in the human RHOA protooncogene
31. Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway
32. Rho prevents apoptosis through Bcl-2 expression: Implications for interleukin-2 receptor signal transduction
33. Inactivation of the small GTP binding protein Rho induces multinucleate cell formation and apoptosis in murine T lymphoma EL4